Cristina Martinez
BSc PhD
Senior Postdoctoral Research Scientist
Research groups
Recent publications
-
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
Journal article
Orlans HO. et al, (2021), Nature Communications, 12
-
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
Journal article
Chandler LC. et al, (2021), Molecular Therapy - Methods & Clinical Development, 22, 52 - 65
-
Accurate Quantification of AAV Vector Genomes by Quantitative PCR
Journal article
Martinez-Fernandez de la Camara C. et al, (2021), Genes, 12, 601 - 601
-
Inclusion of PF68 Surfactant Improves Stability of rAAV Titer when Passed through a Surgical Device Used in Retinal Gene Therapy.
Journal article
Patrício MI. et al, (2020), Mol Ther Methods Clin Dev, 17, 99 - 106
-
Retinal Gene Therapy in X-Linked Retinitis Pigmentosa Caused by Mutations in RPGR: Results at 6 Months in a First in Human Clinical Trial
Conference paper
Cehajic-Kapetanovic J. et al, (2020), MOLECULAR THERAPY, 28, 1 - 1
-
Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
Journal article
Cehajic-Kapetanovic J. et al, (2020), Nature Medicine, 26, 354 - 359
-
RPGR gene therapy presents challenges in cloning the coding sequence
Journal article
Martinez-Fernandez De La Camara C. et al, (2020), Expert Opinion on Biological Therapy, 20, 63 - 71
-
Molecular Strategies for RPGR Gene Therapy.
Journal article
Cehajic Kapetanovic J. et al, (2019), Genes (Basel), 10
-
Fundus autofluorescence abnormalities and microglia/macrophage activation in the Rpgr-deficient mouse
Conference paper
Staurenghi F. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60
-
In vitro expression model for AAV2.VMD2.BEST1 gene therapy vectors
Conference paper
dela Camara CM-F. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60